Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TOBRAMYCIN\TOBRAMYCIN: 395 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
395
Total FAERS Reports
53 (13.4%)
Deaths Reported
153
Hospitalizations
395
As Primary/Secondary Suspect
30
Life-Threatening
3
Disabilities

Active Ingredient: TOBRAMYCIN\TOBRAMYCIN SULFATE ·

First Report: 19840813 · Latest Report: 20241213

What Are the Most Common TOBRAMYCIN\TOBRAMYCIN Side Effects?

#1 Most Reported
Drug ineffective
54 reports (13.7%)
#2 Most Reported
Acute kidney injury
47 reports (11.9%)
#3 Most Reported
Off label use
28 reports (7.1%)

All TOBRAMYCIN\TOBRAMYCIN Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Drug ineffective 54 13.7% 14 27
Acute kidney injury 47 11.9% 0 18
Off label use 28 7.1% 4 12
Renal failure 27 6.8% 6 11
Death 23 5.8% 23 0
Drug resistance 23 5.8% 1 5
Condition aggravated 19 4.8% 2 6
Dyspnoea 17 4.3% 0 14
Pneumonia 17 4.3% 2 15
Infection 15 3.8% 0 12
Wheezing 15 3.8% 0 12
General physical health deterioration 14 3.5% 0 3
Nephropathy toxic 14 3.5% 1 5
Productive cough 14 3.5% 0 11
Pathogen resistance 13 3.3% 4 7
Renal tubular injury 12 3.0% 0 4
Therapeutic product effect incomplete 12 3.0% 0 6
Asthma 11 2.8% 0 8
Drug level increased 11 2.8% 1 6
Hospitalisation 10 2.5% 0 9

Who Reports TOBRAMYCIN\TOBRAMYCIN Side Effects? Age & Gender Data

Gender: 53.9% female, 46.1% male. Average age: 53.9 years. Most reports from: US. View detailed demographics →

Is TOBRAMYCIN\TOBRAMYCIN Getting Safer? Reports by Year

YearReportsDeathsHosp.
2001 1 0 0
2016 4 2 3
2017 1 0 1
2019 1 0 0
2020 2 0 1
2021 1 0 0
2022 3 1 0
2023 5 1 1
2024 65 11 22

View full timeline →

What Is TOBRAMYCIN\TOBRAMYCIN Used For?

IndicationReports
Product used for unknown indication 78
Pneumonia pseudomonal 44
Pseudomonas infection 27
Bronchiectasis 24
Device related infection 21
Arthritis infective 18
Cystic fibrosis 17
Pneumonia 17
Infection prophylaxis 10
Mycobacterium chelonae infection 8

TOBRAMYCIN\TOBRAMYCIN vs Alternatives: Which Is Safer?

TOBRAMYCIN\TOBRAMYCIN vs TOCILIZUMAB TOBRAMYCIN\TOBRAMYCIN vs TOCILIZUMAB-AAZG TOBRAMYCIN\TOBRAMYCIN vs TOCOPHEROL TOBRAMYCIN\TOBRAMYCIN vs TOFACITINIB TOBRAMYCIN\TOBRAMYCIN vs TOFERSEN TOBRAMYCIN\TOBRAMYCIN vs TOLNAFTATE TOBRAMYCIN\TOBRAMYCIN vs TOLODODEKIN ALFA TOBRAMYCIN\TOBRAMYCIN vs TOLTERODINE TOBRAMYCIN\TOBRAMYCIN vs TOLVAPTAN TOBRAMYCIN\TOBRAMYCIN vs TOPAMAX

Official FDA Label for TOBRAMYCIN\TOBRAMYCIN

Official prescribing information from the FDA-approved drug label.